Marker Therapeutics (MRKR) Misses Q3 EPS by 26c
Marker Therapeutics (NASDAQ: MRKR) reported Q3 EPS of ($0.26). Revenue for the quarter came in at $1.93 million.
For earnings history and earnings-related data on Marker Therapeutics (MRKR) click here.
Marker Therapeutics (NASDAQ: MRKR) reported Q3 EPS of ($0.26). Revenue for the quarter came in at $1.93 million.
For earnings history and earnings-related data on Marker Therapeutics (MRKR) click here.